Inventor

SCOTT MARK E

CA26 patents

⚠️ This page may combine multiple inventors who share the name “SCOTT MARK E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCOTT MARK E

MERCK SHARP & DOHME

Regioselective N-2 arylation of indazoles

Substituted indazole compounds as RORgammaT inhibitors and uses thereof

Pyrrolopyrimidines as janus kinase inhibitors

Regioselective N-2 arylation of indazoles

Regioselective N-2 arylation of indazoles

Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof

Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors

Substituted indazole compounds as RORgammaT inhibitors and uses thereof

Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors

Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors

N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors

Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors

SCOTT MARK E

Valve assembly

Inflation device

Leaf lifter and method of use

FEDEX CORP SERVICES INC

Managing logistics information related to a logistics container using a container interface display apparatus

Methods, apparatus, and systems for managing logistics information related to a container having a scale

Methods, apparatus, and systems for generating a content-related notification using a container interface display apparatus

GILEAD SCIENCES INC

Processes for preparing ACC inhibitors and solid forms thereof

Processes for preparing ACC inhibitors and solid forms thereof

Processes for preparing ACC inhibitors and solid forms thereof

GILEAD APOLLO LLC

Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof

ACOBA L L C

Method and system to determine nasal resistance to airflow

EDMONDSON SCOTT D

Pyrrolidine derived beta 3 adrenergic receptor agonists

GUERIN DAVID JOSEPH

Bicyclic diamines as janus kinase inhibitors

BARR KENNETH JAY

Pyrrolidine derived beta 3 adrenergic receptor agonists